Stay updated on AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.

Latest updates to the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page
- Check7 days agoChange DetectedAdditions introduce a glossary display and color-coded change indicators (green for additions, red for deletions) along with a new revision label (v3.4.0) on the Record History page. Deletions remove the old No FEAR Act data note and the v3.3.4 revision text; these are UI and versioning changes rather than core study content—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check42 days agoChange DetectedThe record history now shows Revision: v3.3.3; the items HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedRecord History now shows Revision: v3.3.1 replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedThe site-wide funding lapse notice was removed from the page. The page now shows only the standard study information and navigation.SummaryDifference0.8%

- Check93 days agoChange DetectedA new version was posted showing a Recruitment Status update for NCT05255094. The history now reflects the latest recruitment status for this study.SummaryDifference0.1%

Stay in the know with updates to AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.